⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANL News
Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
globenewswire.com
ANL
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
globenewswire.com
ANL
Morning Market Pulse: Defense-to-Data Bets, Capital Raises, and AI-Powered Platforms Shape the Open
globenewswire.com
SOPA
ANL
DBRG
BNAI
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
globenewswire.com
ANL
Adlai Nortye to Participate in Upcoming Investor Conferences
globenewswire.com
ANL
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
globenewswire.com
ANL